4//SEC Filing
Ridloff Elena 4
Accession 0000950170-25-081200
CIK 0001815442other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 6:30 PM ET
Size
9.6 KB
Accession
0000950170-25-081200
Insider Transaction Report
Form 4
Ridloff Elena
Director
Transactions
- Sale
Common Stock
2025-06-03$45.50/sh−7,200$327,600→ 4,800 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-03−12,000→ 0 totalExercise: $27.67Exp: 2033-06-15→ Common Stock (12,000 underlying) - Exercise/Conversion
Common Stock
2025-06-03$27.67/sh+12,000$332,040→ 12,000 total - Sale
Common Stock
2025-06-03$47.00/sh−4,800$225,600→ 0 total
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 25, 2024 adopted by the reporting person.
- [F2]The shares underlying this stock option are fully vested and exercisable.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001772518
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 6:30 PM ET
- Size
- 9.6 KB